Hsiu-hua L. Ma

128 Academia Road, Taipei 115201
TPQ 11520, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

An Adjuvanted Vaccine-Induced Pathogenesis Following Influenza Virus Infection.

An Adjuvanted Vaccine-Induced Pathogenesis Following Influenza Virus Infection.

Journal: Vaccines

Published: March 01, 2024

A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern.

A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern.

Journal: Emerging microbes & infections

Published: November 17, 2022

Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion.

Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion.

Journal: Journal of medical virology

Published: August 29, 2022

A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants.

A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants.

Journal: Journal of biomedical science

Published: April 20, 2022

Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models.

Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models.

Journal: Science translational medicine

Published: March 01, 2022

Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2.

Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2.

Journal: European journal of medicinal chemistry

Published: January 17, 2022

Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.

Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.

Journal: PloS one

Published: August 04, 2021

Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19.

Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19.

Journal: PLoS pathogens

Published: March 25, 2021

Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection.

Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 16, 2021

CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.

CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.

Journal: Scientific reports

Published: January 15, 2021

Definition of the cellular interactome of the highly pathogenic avian influenza H5N1 virus: identification of human cellular regulators of viral entry, assembly, and egress.

Definition of the cellular interactome of the highly pathogenic avian influenza H5N1 virus: identification of human cellular regulators of viral entry, assembly, and egress.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi

Published: July 09, 2016

Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.

Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 29, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026